Dual roles of glutathione S-transferase mu 1 in the development and metastasis of hepatocellular carcinoma.
CONCLUSION: GSTM1 down-regulation may partially account for ROS-mediated oxidative damage and HCC carcinogenesis. GSTM1 also regulates tumor progression by disrupting the ROS-TP53 axis in HCC cells with different genetic backgrounds.
PMID: 31605953 [PubMed - as supplied by publisher]
Source: Biomedicine and pharmacotherapy = Biomedecine and pharmacotherapie - Category: Drugs & Pharmacology Authors: Lu Y, Zhou J, Zhang J, Wang Z, Yu Y, Miao M, Yao Q Tags: Biomed Pharmacother Source Type: research
More News: Antidoxidants | Cancer | Cancer & Oncology | Carcinoma | Drugs & Pharmacology | Genetics | Hepatocellular Carcinoma | Liver Cancer | Study